Hoag named Dr. Michael Demeure program director of precision medicine, a new program focused on tailoring cancer treatment options for each patient. He’ll lead strategy and development of the program, identify partners, develop a Hoag molecular tumor board, and assess software development.
Hoag Family Cancer Institute now utilizes genomic profiling, a system “previously only accessible at large academic medical centers,” according to a hospital press release, to find molecular abnormalities that create and sustain cancerous tumors.
Hoag also has a location in Irvine. It’s part of Irvine-based St. Joseph Hoag Health.
To view the original article from the Orange County Business Journal, please click here.
